Functional interactions between the thrombin receptor and the T-cell antigen receptor in human T-cell lines

被引:22
|
作者
Joyce, DE
Chen, Y
Erger, RA
Koretzky, GA
Lentz, SR
机构
[1] UNIV IOWA,COLL MED,DEPT INTERNAL MED,IOWA CITY,IA 52242
[2] UNIV IOWA,COLL MED,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242
[3] VET AFFAIRS MED CTR,IOWA CITY,IA 52242
关键词
D O I
10.1182/blood.V90.5.1893
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The proteolytically activated thrombin receptor (TR) is expressed by T lymphocytes, which suggests that thrombin may modulate T-cell activation at sites of hemostatic stress, We examined the relationship between TR function and T-cell activation in the Jurkat human T-cell line and in T-cell lines with defined defects in T-cell antigen receptor (TCR) function, Stimulation with thrombin or the synthetic TR peptide SFLLRN produced intracellular Ca2+ transients in Jurkat cells. As the concentration of TR agonist was increased, peak Ca2+ mobilization increased, but influx of extracellular Ca2+ decreased. TR signaling was enhanced in a TCR-negative Jurkat line and in T-cell lines deficient in the tyrosine kinase lck or the tyrosine phosphatase CD45, both of which are essential for normal TCR function. TCR cross-linking with anti-CD3 IgM desensitized TR signaling in Jurkat cells, but not in CD45-deficient cells. A proteinase-activated receptor (PAR-2)-specific agonist peptide, SLIGKV, produced small Ca2+ transients in both MEG-01 human megakaryocytic cells and Jurkat cells, but was less potent than the TR-specific agonist TFRIFD in both cell types. Like TR signaling, PAR2 signaling was enhanced in TCR-negative or lck-deficient Jurkat clones. These findings provide evidence for functional cross-talk between proteolytically activated receptors and the TCR. (C) 1997 by The American Society of Hematology.
引用
收藏
页码:1893 / 1901
页数:9
相关论文
共 50 条
  • [41] T-CELL RECEPTOR MHC INTERACTIONS IN THE THYMUS AND THE SHAPING OF THE T-CELL REPERTOIRE
    MCDUFFIE, M
    ROEHM, N
    BORN, W
    MARRACK, P
    KAPPLER, JW
    TRANSPLANTATION PROCEEDINGS, 1987, 19 (06) : 111 - 116
  • [42] CUTANEOUS T-CELL LYMPHOMA - UTILITY OF ANTIBODIES TO THE VARIABLE REGIONS OF THE HUMAN T-CELL ANTIGEN RECEPTOR
    HUNT, SJ
    CHARLEY, MR
    JEGASOTHY, BV
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1992, 26 (04) : 552 - 558
  • [43] ANTIGEN SPECIFIC T-CELL HELPER FACTORS PRODUCED BY HUMAN T-CELL LINES
    MOZES, E
    WEISMAN, Z
    DAYAN, M
    ZINGER, H
    BENTWICH, Z
    LYMPHOKINE RESEARCH, 1987, 6 (01): : U101 - U101
  • [44] T-CELL RECEPTOR EXPRESSION IN THE T-CELL MALIGNANCIES
    MORI, N
    OKA, K
    YODA, Y
    ABE, T
    KOJIMA, M
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1990, 93 (04) : 495 - 501
  • [45] T-cell Immunotherapy and Cardiovascular Disease Chimeric Antigen Receptor T-cell and Bispecific T-cell Engager Therapies
    Stein-Merlob, Ashley F.
    Ganatra, Sarju
    Yang, Eric H.
    HEART FAILURE CLINICS, 2022, 18 (03) : 443 - 454
  • [46] THE T-CELL RECEPTOR
    DEBRE, P
    ANNALES DE RECHERCHES VETERINAIRES, 1992, 23 (03): : 258 - 262
  • [47] Chimeric antigen receptor T-cell therapy for T-cell acute lymphoblastic leukemia
    Oh, Bernice L. Z.
    Vinanica, Natasha
    Wong, Desmond M. H.
    Campana, Dario
    HAEMATOLOGICA, 2024, 109 (06) : 1677 - 1688
  • [48] T-Cell Malignant Neoplasms After Chimeric Antigen Receptor T-Cell Therapy
    Storgard, Ryan
    Rejeski, Kai
    Perales, Miguel-Angel
    Goldman, Adam
    Shouval, Roni
    JAMA ONCOLOGY, 2024, 10 (06) : 826 - 828
  • [49] Chimeric Antigen Receptor T-Cell Therapy for T-Cell Acute Lymphocytic Leukemia
    Aldoss, Ibrahim
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2025, 23 (01) : 28 - 29
  • [50] THE T-CELL ANTIGEN RECEPTOR AND SIGNAL TRANSDUCTION
    SAMELSON, LE
    KLAUSNER, RD
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 201 - 201